Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (1 active)

Company-led only

1 result

Therapy	Approach	Progress	Population	Additional Info
AK-antiVEGF by Eli Lilly and AkouosEli Lilly and Company Compare	Gene Therapy	Stage: Phase 1/2Status: Active	Adults · ≥18 yearsUnilateral progressive vestibular schwannoma with profound loss

Eli Lilly and Company · Gene Therapy · Phase 1/2

ActiveTherapeuticStronger sources

Population

Adults · ≥18 years

Unilateral progressive vestibular schwannoma with profound loss

Evidence

trial

Confidence

90%

Indications

Vestibular SchwannomaHearing Loss

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.